PsyMed Ventures
Venture capitalActively deployingBerkeley · Pre-Seed–Series A · 12 people tracked
Also known as PSYMED VENTURES MANAGEMENT LLC
Investment thesis
PsyMed Ventures backs founders working to transform the mental and brain illness epidemic through frontier science and technology. Its focus spans neurotech and human augmentation, brain-computer interfaces, precision neuroscience, artificial intelligence for early detection and diagnosis, new therapeutic modalities (genetic, RNA, cell-based), holistic and neurometabolic approaches, platforms and novel compounds, and digital health and therapeutics. The firm seeks companies that align healing, responsibility, and profitability, aiming to shift care from generalized to individualized while addressing root causes of mental and neurological disease.
Source: firm website, verified Aug 7, 2026.
Team · 12 people
from the firm's website & public directoriesWhat they invest in
from 14 of 28 portfolio companiesBiotech ×11Digital Health ×9Healthtech ×6Mental Health ×5AI & Machine Learning ×4Medical Devices ×4Deep Tech ×2AgTech ×1
HQs:United States×4
Investments · 28 tracked
founders shown can be your intro pathAncilia uses CRISPR technology to engineer bacterial products with resistance to destructive viruses, enabling their use as live biotherapeutics.
Biotech
Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism.
BiotechDigital HealthMental Health
Dr. John Krystal(Co-founder & CEO)Dina Burkitbayeva(Co-founder)
Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.
AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US
Jonathan Sporn(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inJONATHAN SPORN(Founder)inThomas Kevin Murphy, Ph.D.(Executive Officer)Andrew Kruegel, Ph.D.(Executive Officer)
Journey Clinical provides ketamine-assisted psychotherapy (KAP) for depression, anxiety, and PTSD, partnering patients with licensed therapists and medical teams while coordinating with major insurance providers.
Digital HealthMedical DevicesMental Health
Maya Health (Naitur) builds compliance-focused AI automation for independent health and wellness practices, covering intake-to-EMR sync, follow-ups, lab result delivery, rating-scale scoring, and safety escalation.
AI & Machine LearningDigital HealthHealthtech
Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.
AI & Machine LearningBiotechHealthtechMental HealthSan Francisco, US
Dillan DiNardo(Founder/CEO)inTom Ray(Founder)in
BoardRand Hindi(Director)in
Motif Neuro develops neural devices to monitor and regulate mental health and performance, with an initial focus on treatment-resistant depression using bioelectronic implants called DOT that are deployed via outpatient procedure.
BiotechDigital HealthHealthtechMedical DevicesHouston, US
Anthony Arnold(Director)Jacob Robinson(Executive Officer, Director)Thomas M. Shehab(Director)Amy Kruse(Director)
Reset Pharma is a neuro-biotechnology company developing first-in-class, psilocybin-inspired therapies aimed at treating demoralization syndrome and psychological trauma in people facing life-altering diseases such as cancer.
BiotechDigital HealthMental Health
Transcranial focused ultrasound for mental health
Precision biologics for neuroinflammation
Integrated solution for cancer-specific behavioral health
Marketplace for transformational mental health modalities
TRIPP provides immersive meditation and mindfulness experiences available through a mobile app and VR headset platform.
AgTechMental HealthWellness & FitnessVenice, US
Tim Chang(Director)Nanea Reeves(Executive Officer, Director)Zachary Norman(Executive Officer, Director)Kevin Keeland(Executive Officer)
Frequently asked questions
- What stage does PsyMed Ventures invest at?
- PsyMed Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does PsyMed Ventures focus on?
- PsyMed Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Longevity, Medical Devices, Mental Health, Wellness & Fitness.
- Where is PsyMed Ventures located?
- PsyMed Ventures is headquartered in Berkeley, US.
Media · Podcasts & interviews
featuring the teamInvesting In The Next Frontiers of Mental Health (Greg Kubin, PsyMed Ventures)
Scott Britton · Greg Kubin
Podcast E047: Dina Burkitbayeva of PsyMed Ventures
Female VC Lab · Dina Burkitbayeva
Images
Co-investors · 7
Mayfield Fund is a venture capital firm publishing perspectives on artificial intelligence, focusing on what it calls the Collaborative Intelligence era where humans and AI work together.
RA Capital invests in public and private healthcare and life science companies developing pharmaceuticals, medical devices, and diagnostic tools. The firm operates as a crossover fund across multiple investment stages.
Artis Ventures is a venture capital firm focused on supporting founders reimagining the systems that sustain life, spanning from cellular biology to broader societal impact.
Baruch Future Ventures is a climate-tech focused family investment firm that backs entrepreneurs building companies in the climate economy.
What If Ventures is a venture capital firm investing in transformative technology, with a focus on healthcare/mental health and defense technology.
Mystic Ventures is an early-stage investor backing teams in psychedelic medicine and consciousness expansion, focusing on companies at the intersection of biotechnology, AI, and longevity.
Firms observed investing alongside PsyMed Ventures, from public investor directories. Shared companies are the overlap with PsyMed Ventures's recorded portfolio.
Similar investors
Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
Proton Enterprises is a venture development firm that partners with leaders by combining capital, time, and talent to build mission-driven businesses, while also investing broadly and backing emerging fund managers.
Pave Health Ventures is an early-stage investor and company builder focused on health, backing founders from the ideation stage across products, technology, and tech-enabled services.
Embryo Ventures is an early-stage venture firm backing founders building technologies across human health and human experience, from clinical and consumer health to essential life infrastructure.



















